Literature DB >> 1702931

Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases.

T Kamio1, K Shigematsu, K Kawai, H Tsuchiyama.   

Abstract

Using immunoperoxidase methods, 94 human adrenal tumors were examined for evidence of immunoreactivity and receptor expression of insulinlike growth factor I (IGF-I) and insulin. The frequency of IGF-I in adrenocortical carcinomas was significantly higher than that in adenomas of the adrenal glands. The adrenocortical carcinomas showed strong intensity of staining for IGF-I, IGF-I receptors, and insulin receptors. A significant correlation between immunoreactivity and receptor expression of both IGF-I and insulin was found only in the adrenocortical carcinomas. The adrenocortical adenomas with Cushing's syndrome and pheochromocytomas, more than adrenocortical adenomas with Conn's syndrome, also stained strongly for insulin receptors. Thus the IGF-I and insulin probably play a role in the growth of adrenocortical carcinoma tissues, possibly through autocrine mechanisms. The expression of insulin receptors in adrenocortical adenomas in the presence of Cushing's syndrome and pheochromocytomas may be associated with functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702931      PMCID: PMC1886050     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Effects of IGF-I on proliferation and steroidogenesis of cultured adrenal zona glomerulosa cells.

Authors:  N Horiba; K Nomura; N Hizuka; K Takano; H Demura; K Shizume
Journal:  Endocrinol Jpn       Date:  1987-08

2.  In vitro spontaneous and adrenocorticotropin-dependent maturation of the steroidogenic pathway of ovine fetal adrenal cells.

Authors:  A M Cathiard; A Crozat; P Durand; J M Saez
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

3.  Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution.

Authors:  V K Han; P K Lund; D C Lee; A J D'Ercole
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

Review 4.  Intracellular pathways and mechanisms of sorting in receptor-mediated endocytosis.

Authors:  V L Shepherd
Journal:  Trends Pharmacol Sci       Date:  1989-11       Impact factor: 14.819

5.  Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells.

Authors:  M K Dahmer; R L Perlman
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

6.  Hormonal regulation of insulin-like growth factor I secretion by bovine adrenal cells.

Authors:  A Penhoat; D Naville; C Jaillard; P G Chatelain; J M Saez
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

7.  Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.

Authors:  F Minuto; P Del Monte; A Barreca; A Alama; G Cariola; G Giordano
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

8.  Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas.

Authors:  J V Tricoli; L B Rall; C P Karakousis; L Herrera; N J Petrelli; G I Bell; T B Shows
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  Expression of insulin-like growth factor-II transcripts in Wilms' tumour.

Authors:  A E Reeve; M R Eccles; R J Wilkins; G I Bell; L J Millow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  Adrenal cortical carcinoma. A clinicopathological and immunohistochemical study of 91 autopsy cases.

Authors:  M Nakano
Journal:  Acta Pathol Jpn       Date:  1988-02
View more
  14 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

2.  Adrenal tumors in patients with chronic hepatitis C.

Authors:  Nora V Bergasa; Geraldo E Holguin; Milka Martinez; Yaw-Ling Chen; Donald Baumstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-06

Review 3.  Discerning malignancy in resected adrenocortical neoplasms.

Authors:  H Sasano; T Suzuki; T Moriya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

4.  Insulin-like growth factor-II receptor expression in normal and N-methyl-N'-nitro-nitrosoguanidine exposed cell lines: assessment by flow cytometry.

Authors:  W H Thornton; L Barnett; R S MacDonald
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

Review 5.  Genetic background of adrenocortical tumor development.

Authors:  M Kjellman; C Larsson; M Bäckdahl
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

6.  The relationship between adrenal incidentalomas and mortality risk.

Authors:  Michio Taya; Viktoriya Paroder; Eran Bellin; Linda B Haramati
Journal:  Eur Radiol       Date:  2019-04-16       Impact factor: 5.315

7.  Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?

Authors:  C T Bahadir; G C Ecemis; H Atmaca
Journal:  J Endocrinol Invest       Date:  2018-03-14       Impact factor: 4.256

8.  Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue.

Authors:  Samir Faical; Rui M. B. Maciel; Vania Nose-Alberti; Marivania C. Santos; Claudio E. Kater
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

9.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

10.  The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors.

Authors:  Sofia S Pereira; Tiago Morais; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2013-08-28       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.